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Clapp PW, Pawlak EA, Lackey JT, Keating JE, Reeber SL,
Glish GL, Jaspers I. Flavored e-cigarette liquids and cinnamalde-
hyde impair respiratory innate immune cell function. Am J Physiol
Lung Cell Mol Physiol 313: L278–L292, 2017. First published May
11, 2017; doi:10.1152/ajplung.00452.2016.—Innate immune cells of
the respiratory tract are the first line of defense against pathogenic and
environmental insults. Failure of these cells to perform their immune
functions leaves the host susceptible to infection and may contribute
to impaired resolution of inflammation. While combustible tobacco
cigarettes have been shown to suppress respiratory immune cell
function, the effects of flavored electronic cigarette liquids (e-liquids)
and individual flavoring agents on respiratory immune cell responses
are unknown. We investigated the effects of seven flavored nicotine-
free e-liquids on primary human alveolar macrophages, neutrophils,
and natural killer (NK) cells. Cells were challenged with a range of
e-liquid dilutions and assayed for their functional responses to patho-
genic stimuli. End points included phagocytic capacity (neutrophils
and macrophages), neutrophil extracellular trap formation, proinflam-
matory cytokine production, and cell-mediated cytotoxic response
(NK cells). E-liquids were then analyzed via mass spectrometry to
identify individual flavoring components. Three cinnamaldehyde-
containing e-liquids exhibited dose-dependent broadly immunosup-
pressive effects. Quantitative mass spectrometry was used to deter-
mine concentrations of cinnamaldehyde in each of the three e-liquids,
and cells were subsequently challenged with a range of cinnamalde-
hyde concentrations. Cinnamaldehyde alone recapitulated the im-
paired function observed with e-liquid exposures, and cinnamalde-
hyde-induced suppression of macrophage phagocytosis was reversed
by addition of the small-molecule reducing agent 1,4-dithiothreitol.
We conclude that cinnamaldehyde has the potential to impair respi-
ratory immune cell function, illustrating an immediate need for further
toxicological evaluation of chemical flavoring agents to inform reg-
ulation governing their use in e-liquid formulations.
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SMOKING CONTINUES TO BE the leading cause of preventable
death, accounting for 12% of all mortalities among adults
worldwide (69a). A link between cigarette smoke exposure,
suppression of respiratory immune responses, and enhanced
susceptibility to respiratory infection is well established (28–
30, 32, 50, 51, 56). While tobacco use is steadily declining in
the United States, electronic cigarettes (e-cigarettes) are rap-
idly gaining popularity, particularly among teens and young
adults (4) who often perceive these products as less harmful
than traditional cigarettes (2). This perception is in part the
result of targeted marketing that identifies these products as a
“safer alternative” to traditional cigarettes (55); however, little
is known regarding the effects of “vaping” on respiratory
innate immune cell function. A recent study by Sussan et al.
reported that mice exposed to e-cigarette aerosols exhibited
impaired bacterial clearance and increased susceptibility to
respiratory virus infection (64). Furthermore, lung macro-
phages from these exposed mice exhibited reduced phagocytic
capacity. More recently, Hwang et al. exposed human epithe-
lial cell lines, murine alveolar macrophages, and human neu-
trophils to “e-cigarette vapor extract” and observed dose-
dependent cytotoxicity and reduced antimicrobial activity
against Staphylococcus aureus (31). The findings in both
publications were largely attributed to the immunosuppressive
effects of nicotine; however, reactive carbonyls present in
these flavored e-liquids and generated by e-cigarette devices
may also play a role in the observed immunomodulatory
effects (18, 38, 61).
E-cigarette devices aerosolize flavored e-liquids, which are
typically composed of humectants [propylene glycol (PG)
and/or vegetable glycerin (VG)], chemical flavorings, and
nicotine. There are currently more than 7,700 commercially
available e-liquids which contain flavorings that have not been
evaluated for inhalational toxicity (73). While many of these
flavorings are classified as generally recognized as safe
(GRAS) for oral consumption by the United States Food and
Drug Administration (FDA), prolonged inhalation of some
GRAS flavorings, such as diacetyl, 2,3-pentanedione, and
acetoin, can cause irreversible lung disease (27b, 27c, 39).
GRAS chemicals commonly used as e-liquid flavoring agents
include aliphatic aldehydes (for fruity flavors) and aromatic
aldehydes (for sweet and spicy flavors) (27a, 68a). The Flavor
and Extract Manufacturers Association (FEMA) has identified
over 1,000 GRAS flavorings that may pose a respiratory hazard
due to possible volatility and irritant properties (18a); however,
it is unclear whether these flavorings, in the context of e-cig-
arette exposures, directly impact respiratory innate immune
cells. Previous studies have demonstrated that vanillin and
cinnamaldehyde, aromatic aldehydes commonly used as e-liq-
uid flavoring and odorant agents, can suppress macrophage
function (14, 34, 36, 37, 45, 47, 57, 72). However, most of
these studies were conducted in nonhuman cell lines without
Address for reprint requests and other correspondence: I. Jaspers, Univ. of
North Carolina at Chapel Hill, 104 Mason Farm Rd., Chapel Hill, NC
27599-7310 (e-mail: ilona_jaspers@med.unc.edu).
direct relevance to the lung. Consequently, how exposure of
innate immune cells patrolling the respiratory tract to these
flavoring chemicals induces potential functional changes is
unknown.
The testing paradigm we chose to address this knowledge
gap was to screen popular e-liquids for their potential to alter
innate immune cell function, identify common flavoring agents
in the e-liquids eliciting a response, and investigate whether
exposure to a shared flavoring agent alone could recapitulate
the observed response. To this end, we collected alveolar
macrophages, peripheral blood neutrophils, and natural killer
(NK) cells from healthy nonsmoker volunteers and exposed the
cells to varying dilutions of nicotine-free flavored e-liquids and
evaluated changes in normal immune functions. The chemical
composition of e-liquids that altered immune cell responses
was determined, and a shared chemical flavoring, cinnamalde-
hyde, was investigated for its role in the e-liquid-induced
effects on respiratory immune cell function.
MATERIALS AND METHODS
Subjects. Healthy individuals between the ages of 18 and 49 yr
were recruited to donate venous blood for the isolation of neutrophils
or NK cells or to undergo bronchoscopy and bronchoalveolar lavage
for the collection of alveolar macrophages. Subjects donating venous
blood were healthy, nonsmoking, nonvaping adults who are not
routinely exposed to secondhand smoke. Exclusion criterial included
pregnant or nursing females or individuals with a history of egg
allergy, allergic rhinitis, aspirin therapy, asthma, immunodeficiency
(human immunodeficiency virus or other), Guillain-Barre Syndrome,
chronic obstructive pulmonary disease (COPD), cardiac disease, any
chronic cardiorespiratory condition, or fever/respiratory illness within
3 wk before entry into study.
Subjects undergoing bronchoscopy received a physical examina-
tion, a routine blood panel with complete blood count and differential,
serum electrolyte, glucose, and liver enzyme testing. Female subjects
had to have a negative urine pregnancy test before bronchoscopy, and
all volunteers were required to be free of chronic cardiovascular or
respiratory illness and of acute respiratory illness within the proceed-
ing 3 wk. All subjects undergoing bronchoscopy had forced expiratory
volume in s (FEV1) and forced vital capacity (FVC) 80% predicted
and FEV1/FVC 80% predicted normal for height and age, and were
nonvapers and nonsmokers with no smoking history.
Subjects were matched for sex, age, and body mass index between
experimental conditions. Participants in this study were not currently
taking immunosuppressive drugs, including corticosteroids. Informed
consent was obtained from all subjects, and all studies were approved
by the University of North Carolina at Chapel Hill School of Medicine
Institutional Review Board.
Alveolar macrophage isolation. Bronchoalveolar lavage (BAL)
fluid was collected during bronchoscopy as previously described (23).
Briefly, a flexible fiber optic bronchoscope was inserted transnasally
and wedged in a subsegment of the medial segment of the right middle
lobe (5th or 6th generation). Saline was instilled and immediately
aspirated to recover alveolar leukocytes. Recovered BAL fluid was
centrifuged, and cells (95% alveolar macrophages) were collected in
RPMI-1640 medium (Thermo Fisher Scientific, Waltham, MA).
Neutrophil isolation. Venous blood was collected in Vacutainer
tubes containing ethylenediamine tetraacetic acid (EDTA) and al-
lowed to cool to room temperature with gentle rocking before cell
isolation. Neutrophils were isolated by density centrifugation of ve-
nous blood over Histopaque 1119 (Sigma-Aldrich, St. Louis, MO) and
subsequently over a discontinuous Percoll (GE Healthcare Life Sci-
ences, Marlborough, MA) gradient as previously described (10, 19).
Isolated neutrophils were resuspended in RPMI-1640 medium con-
taining 10 mM HEPES buffer and 0.5% fetal bovine serum (FBS).
Cells were incubated at 37°C and 5% CO2 for 30 min before
challenges.
NK cell isolation. Venous blood was collected in Vacutainer
tubes containing heparin and allowed to cool to room temperature
with gentle rocking before cell isolation. Blood was diluted 1:4
with PBS and centrifuged over Lymphoprep density gradient
medium (STEMCELL Technologies, Vancouver, Canada) to frac-
tionate whole blood components. The plasma and peripheral blood
mononuclear cell fractions were harvested and briefly washed with
PBS. NK cells were isolated from the peripheral blood mononuclear
cell fraction using negative antibody selection with the Dynabeads
Untouched Human NK Cell negative selection kit (Thermo Fisher
Scientific). Purified NK cells were kept at 37°C and 5% CO2 in
RPMI-1640 medium with 10% FBS before challenges.
Flavored e-cigarette liquids. A panel of seven flavored nicotine-
free e-liquids was purchased from a local vendor (The Vapor Girl,
Chapel Hill, NC). E-liquids were selected for this study based on
either a “top-seller” designation (“Menthol Tobacco” and “Solid
Menthol”) or their likelihood to contain chemical flavorings identified
as potential respiratory hazards by FEMA, such as cinnamaldehyde
(“Hot Cinnamon Candies,” “Kola,” and “Sini-cide”) and isoamyl
acetate (“Banana Pudding” and “Banana”). E-liquids were stored in
opaque glass bottles at room temperature and were diluted for use at
the time of each experiment. All e-liquids used in this study were
reported by the manufacturer to contain the humectants PG and VG at
relative proportions of 55% and 45%, respectively. A mixture of 55%
PG (Thermo Fisher Scientific) and 45% VG (Sigma-Aldrich) was
used as a vehicle control for all e-liquid experiments.
Stimulation and quantification of neutrophil extracellular traps.
Neutrophils were seeded at a density of 1  105 in 100 l volume/
well of a cell culture-treated 96-well plate and allowed to incubate at
37°C and 5% CO2 for 30 min. Cells were then challenged with a final
concentration of 1.0% e-liquid diluted in cell culture medium with or
without 25 nM phorbol 12-myristate,13-acetate (PMA; Sigma-Al-
drich), a protein kinase C (PKC) activator and potent neutrophil
extracellular trap (NET) agonist. Wells were assayed for extracellular
chromatin every hour during a 4-h challenge. Chromatin extruded by
activated neutrophils was digested with 500 mU/ml micrococcal
nuclease (Worthington Biochemical, Lakewood, NJ). Micrococcal
nuclease activity was quenched with 5 mM EDTA following a 10-min
digestion at 37°C. Chromatin released at each time point was quan-
tified using the Picogreen double-stranded DNA kit (Life Technolo-
gies, Carlsbad, CA) according to the manufacturer’s protocol.
Immunofluorescent analysis of NETs. Neutrophils were seeded on
13-mm round glass coverslips (0.15 mm thick) and challenged with
1.0% e-liquid diluted in cell culture medium with or without 25 nM
PMA. Cells were fixed with 4% paraformaldehyde (PFA; Sigma-
Aldrich) every hour during a 4-h challenge, and immunolabeling was
conducted as described by Brinkmann et al. (10). Neutrophils were
blocked [5% normal donkey serum (Jackson ImmunoResearch, West
Grove, PA), 1% gelatin from cold water fish skin (Sigma-Aldrich),
1% bovine serum albumin (Sigma-Aldrich), and 0.05% Tween 20
(Sigma-Aldrich) in PBS (GIBCO/Thermo Fisher Scientific)] and
incubated with a mouse anti-human neutrophil elastase primary anti-
body (Dako, Carpentaria, CA) that was detected with an Alexa Fluor
488-conjugated secondary antibody (Jackson ImmunoResearch).
Negative controls were conducted using Isotype-matched (IgG1)
labeling of NETs at each time point. Chromatin was labeled with
Hoechst 33342 (Thermo Fisher Scientific). Coverslips were mounted
on microscope slides with ProLong Gold Antifade Mountant (Thermo
Fisher Scientific), and the edges were sealed with clear fingernail
polish. Cells were imaged using a Nikon Digital Eclipse C-1 modular
confocal microscope and Plan Apo VC 60  /1.40 oil objective.
Neutrophil and alveolar macrophage phagocytosis. Neutrophils
isolated from venous blood were seeded at a density of 1  105
cells/well of a black clear-bottom 96-well plate in RPMI-1640 media
with 10 mM HEPES buffer (Sigma-Aldrich) and 0.5% FBS (GIBCO/
Thermo Fisher Scientific). Cells were allowed to incubate at 37°C and
5% CO2 for 30 min. Neutrophils were then challenged in triplicate
with a final concentration of 1, 0.5, or 0.25% e-liquid diluted in cell
culture medium for 30 min. Opsonized pHrodo Red S. aureus Bio-
Particles (Thermo Fisher Scientific) were prepared according to the
manufacturer’s instructions and added to each well following e-liquid
challenge. Neutrophils and BioParticles were incubated at 37°C and
5% CO2 for an additional 4 h to assess e-liquid-induced changes in
phagocytic capacity.
Cells obtained from BAL fluid were seeded at a density of 5  104
cells/well of a black clear-bottom 96-well plate (Corning Life Sci-
ences, Tewksbury, MA) in RPMI-1640 medium with 10% FBS. Cells
were allowed to incubate at 37°C and 5% CO2 for 2 h. Nonadherent
cells were then aspirated, thereby enriching the alveolar macrophage
population. Adherent alveolar macrophages were challenged in trip-
licate with cell culture medium containing 1, 0.5, or 0.25% flavored
e-liquid for 1 h. Following e-liquid challenge, opsonized pHrodo S.
aureus BioParticles were added to the cells and allowed to incubate as
described above.
To assess whether nicotine altered e-liquid-induced effects on
neutrophil phagocytosis, nicotine (Sigma-Aldrich) was added to the
Kola, Hot Cinnamon Candies, Sini-cide, and “PG/VG vehicle” e-liq-
uids at concentrations commonly stocked in vape shops (2.4, 1.8, 1.2,
and 0.6%). Nicotine-containing e-liquids were then diluted to 0.25%
in cell culture medium, neutrophils were challenged as described
above, and opsonized pHrodo Red S. aureus BioParticles were added
to assess phagocytosis.
Phagocytosis of bioparticles was quantified using a CLARIOstar
fluorescent microplate reader (BMG Labtech, Offenburg, Germany)
by assessing fluorescence emission at 585 nm. Cell-free negative
control wells were used to normalize for background fluorescence
resulting from e-liquid challenge at 1, 0.5, or 0.25%. Data are
presented as percent phagocytosis observed in the PG/VG vehicle at
each dilution tested.
Dithiothreitol competition assay. Alveolar macrophages obtained
from BAL fluid were seeded on black clear-bottom 96-well plates and
allowed to incubate as described above. Nonadherent cells were
removed, and adherent alveolar macrophages were challenged with
cell culture medium alone, 500 M cinnamaldehyde, 500 M dithio-
threitol (DTT; Sigma-Aldrich), or a combination of 500 M cinna-
maldehyde and 500 M DTT for 30 min. Following challenge,
opsonized pHrodo S. aureus BioParticles were added to the cells and
incubated for an additional 4 h. Phagocytosis of bioparticles was
quantified using the CLARIOstar fluorescent microplate reader as
described above.
Immunofluorescent analysis of macrophage phagocytosis. Alveolar
macrophages were seeded on 13-mm round glass coverslips (0.15 mm
thick) at 2  105 cells/well of a cell culture-treated 24-well plate.
Cells were allowed to incubate at 37°C and 5% CO2 for 2 h and were
challenged with 1, 0.5, or 0.25% dilutions of flavored e-liquid for 1 h
as described above. Opsonized pHrodo Red S. aureus BioParticles
were added to each well according to the manufacturer’s protocol, and
cells were fixed with 4% PFA after 4 h. Following 30 min fixation at
4°C, PFA was aspirated, and cells were blocked for 1 h with 5%
normal donkey serum, 1% gelatin from cold water fish skin, 1%
bovine serum albumin, and 0.05% Tween 20 in PBS (block buffer).
AlexaFluor 488-conjugated phalloidin (Thermo Fisher Scientific) and
Hoechst 33342 were diluted in block buffer to the manufacturer’s
recommended concentrations and applied to the cells for 1 h. Cover-
slips were washed with PBS and mounted on microscope slides with
ProLong Gold Antifade Mountant, and the edges were sealed with
clear fingernail polish. Cells were imaged using a Nikon Digital
Eclipse C-1 modular confocal microscope and Plan Apo VC 60  /
1.40 oil objective.
NK cell killing assay. NK cells (1  105) were added to duplicate
polypropylene flow cytometry tubes with 0.25% e-liquids diluted in
cell culture medium for 1 h. During e-liquid incubation, K-562 human
erythromyeloblastoid leukemia cells (ATCC, Manassas, VA) were
labeled with carboxyfluorescein succinimidyl ester (Cayman Chemi-
cal, Ann Arbor, MI). Following e-liquid challenge, 3.2  104 car-
boxyfluorescein succinimidyl ester-labeled K-562 cells were added to
each tube of NK cells and incubated for 4 h at 37°C and 5% CO2. The
entire cell suspension was then pelleted, stained with the LIVE/DEAD
fixable dead cell stain kit (Thermo Fisher Scientific), and fixed with
0.5% PFA, and data were acquired on a BD LSRII Flow Cytometer as
described in our previous studies (46).
Enzyme-linked immunosorbent assay. Supernatants were harvested
from alveolar macrophages and neutrophils after challenge with
diluted e-liquids. Specifically, cells collected from BAL were seeded
in cell culture-treated 96-well plates as described above. Media
containing 1, 0.5, or 0.25% flavored e-liquid or PG/VG vehicle was
added to each well, and supernatants were collected after 24 h.
Neutrophils were seeded at a density of 1  105 cells/well of cell
culture-treated 96-well plates in RPMI-1640 media with 0.5% FBS
and stimulated with 1, 0.5, or 0.25% of each e-liquid flavor for 4 h,
followed by collection of supernatants. Medias collected postchal-
lenge were stored at 20°C until analyzed. Interleukin 8 (IL-8) and
interleukin 6 (IL-6) were quantified in cell culture supernatants via
commercially available enzyme-linked immunosorbent assay (ELISA)
kits (BD Biosciences, San Jose, CA).
Vaped e-liquid condensate. Vaped e-liquid condensates (VEC) of
“PG/VG (vehicle control),” Kola, Hot Cinnamon Candies, and Sini-
cide were generated as described by Olmedo et al. (52). Briefly, e-ciga-
rette aerosol was produced by connecting a LAVABOX DNA 200 Box
Mod (Volcano e-Cigs, Honolulu, HI) and a SMOK TFV4 Mini Tank
with a sub-ohm (0.37) TF-CLP2 Clapton Coil (SMOKtech, Shen-
zhen, China) to a 16-cm length of tubing (4.8 mm ID; Masterflex L/S
15, Vernon Hills, IL). A peristaltic pump (drive number 07522–20 and
head number 77200–62; Cole-Parmer, Vernon Hills, IL) was used to
pull aerosol from the e-cigarette device at a flow rate of 1 l/min. One
puff of aerosol was generated every 30 s for 10 min (20 puffs total)
using an output setting of 60 watts. Vaped aerosol was pumped
through a series of alternating 250-l pipette tips and Tygon tubing
(1.5 mm ID, S3 E-3603; Saint-Gobain) to allow the aerosol to cool
and condense. VEC for each e-liquid was collected in a sterile 1.5-ml
microcentrifuge tube for quantitation of cinnamaldehyde content.
Alveolar macrophages and neutrophils were then seeded as descri-
bed above and challenged with a 0.25% dilution of each VEC or
unheated e-liquid to assess whether the vaping process altered e-liq-
uid-induced effects on phagocytic function.
Mass spectrometry of e-liquids. Qualitative e-liquid analysis was
performed on a Bruker Scion 456 gas chromatograph (GC)-triple
quadrupole mass spectrometer (Bruker, Billerica, MA) using an Agi-
lent DB-5MS capillary column (30 m, 0.25 mm ID, 0.25 M film;
Agilent Technologies, Santa Clara, CA). Samples were prepared by
diluting 100 l of e-liquid in 1 ml of methanol (optima grade) and
vortexing for 30 s. Splitless injections (2 l) were performed using a
Bruker CP-8400 autosampler.
Cinnamaldehyde was quantified in e-liquid and VEC samples using
the same GC-mass spectrometry (MS) system and operating condi-
tions. Cinnamaldehyde standard solutions were prepared to concen-
trations of 7.22, 3.61, 1.44, 0.722, 0.361, and 0.181 mM in methanol
(Optima grade). A calibration curve was generated using standard
addition methods by diluting the Sini-cide, Hot Cinnamon Candies,
and Kola e-liquids to ratios of 1:500, 1:100, and 1:10, respectively, in
the standard solutions. Dilution factors were selected to ensure that
cinnamaldehyde concentrations fell within the linear range of the
calibration curve. Analyses were performed in triplicate. Multiple-
reaction monitoring was used for quantitation of the Kola e-liquid,
since it provided the limit of detection needed for the lower cinnam-
aldehyde concentration. Two reactions were used: mass-to-charge
ratio (m/z) 131–77 and m/z 131–103. The m/z 77 product ion was used
for quantitation with 90% of the scan time, and the m/z 103 product
ion was used for qualification with 10% of the scan time to provide
increased selectivity. Argon was used as the collision gas at a pressure
of 1.5 mTorr, and the collision energy was 20 eV.
The GC oven was programmed to hold the temperature at 50°C for
2 min, ramp to 300°C at a rate of 15°C/min, and hold at 300°C for
6.33 min for a total run time of 25 min. The transfer line and electron
ionization source were held at 250°C throughout the analysis. Com-
pound identification and peak integration were done using AMDIS
GC/MS Analysis software based on spectral matching with the NIST
Mass Spectral Library (2011).
Statistics. Data were generated from cells isolated from a minimum
of n  3 individuals, as noted the legends for Figs. 1–8. When
appropriate, data are expressed as a percentage of PG/VG vehicle
control. Macrophage and neutrophil data were analyzed using a
two-way ANOVA with Fisher’s least-significant difference posttest.
NK cell-mediated cytotoxicity data were analyzed using a one-way
ANOVA with a Dunn’s multiple-comparison test. All statistical tests
were performed using GraphPad Prism Version 7. A P value of 	0.05
was considered to be significant.
RESULTS
Effects of flavored e-liquids on alveolar macrophages. The
effects of flavored e-liquids on alveolar macrophage phagocy-
tosis were assessed by challenging cells with 1, 0.5, and 0.25%
e-liquids diluted in cell culture medium, followed by incuba-
tion with S. aureus BioParticles. The BioParticles used for this
study emit a minimal fluorescent signal at physiological pH
(~7.4); however, fluorescence intensity increases as particles
are phagocytosed and subjected to an acidic pH in phago-
somes. Exposure of alveolar macrophages to the highest dilu-
tion (1%) of PG/VG vehicle alone produced a slight but
significant reduction in BioParticle phagocytosis (Fig. 1A). Of
the seven e-liquids tested, only Kola (1%) and Sini-cide (1, 0.5,
and 0.25%) significantly suppressed phagocytosis compared
with the PG/VG vehicle control (Fig. 1B). Fluorescent confocal
microscopic analysis of macrophages challenged with 0.25%
Sini-cide revealed normal alveolar macrophage morphology
but loss of phagocytic function and inability to engulf labeled
BioParticles (Fig. 1C). The suppression of macrophage phago-
cytosis induced by Sini-cide was validated by flow cytometry.
Flow analysis confirmed that Sini-cide at all three dilutions
used (1, 0.5, and 0.25%) significantly reduced phagocytic
function (Fig. 1D). The reduction in phagocytosis observed
with the 1% Sini-cide challenge can be attributed to e-liquid-
induced cytotoxicity; however, the 0.5 and 0.25% dilutions
significantly suppressed phagocytosis without reducing mac-
rophage viability (Fig. 1E).
In addition to changes in phagocytic function, e-liquid-
induced alterations in alveolar macrophage proinflammatory
cytokine production were evaluated. Acute exposure to 1%
Kola e-liquid significantly increased IL-6 secretion, whereas
0.5% Sini-cide challenge significantly suppressed IL-6 secre-
Fig. 1. Effects of flavored e-liquids on alveolar macrophage phagocytosis. Alveolar macrophages were challenged with 1, 0.5, and 0.25% dilutions of propylene 
glycol/vegetable glycerin (PG/VG) vehicle (A) or electronic cigarette liquids (e-liquids, B) for 1 h before the addition of Staphylococcus aureus BioParticles. 
Phagocytosis was assessed 4 h after the addition of Bioparticles (n 10 experiments). C: fluorescent confocal microscopy of alveolar macrophages challenged 
with PG/VG vehicle (left) or “Sini-cide” e-liquid (0.25%, right). White arrows, nonphagocytosed and extracellular BioParticles. D: e-liquid-induced suppression 
of phagocytosis was validated by flow cytometry (n 3). E: flow-based analysis of cell viability (n 3). Data are presented as means SE. Significance: **P
0.01 and ***P 0.001 compared with vehicle control.
tion relative to the PG/VG vehicle control (Fig. 2A). Sini-cide
e-liquid significantly suppressed alveolar macrophage IL-8
secretion across all dilutions tested (Fig. 2B).
Effects of flavored e-liquids on neutrophils. We next deter-
mined the effects of flavored e-liquids on the phagocytic
capacity of human primary neutrophils. Similar to the effect on
alveolar macrophages, challenge with the 1% dilution PG/VG
vehicle alone significantly reduced neutrophil phagocytosis
(Fig. 3A). Of the seven flavored e-liquids tested, Hot Cinnamon
Candies, Banana Pudding, Menthol Tobacco, Banana, and
Sini-cide reduced neutrophil phagocytosis across all dilutions
in a dose-dependent manner (Fig. 3B). Although toxicity was
observed at higher concentrations for Kola (1%) and Sini-cide
(1 and 0.5%) flavors, none of the flavors showed significant
toxicity at 0.25%, suggesting that suppression of phagocytosis
was not the result of e-liquid-induced cytotoxicity (lactate
dehydrogenase release assay; data not shown). Interestingly,
Sini-cide challenge resulted in a dose-dependent change in
neutrophil phagocytosis that was opposite of that observed
in the other e-liquids. We observed that BioParticle fluores-
cence intensity (i.e., phagocytosis) increased as the percent
Sini-cide challenge increased; however, this is likely be-
cause of cell lysis, which we only observed with the 0.5 and
1.0% Sini-cide challenges. Furthermore, fluorescent confo-
cal microscopic analysis of neutrophils challenged with
0.25% Hot Cinnamon Candies and Sini-cide revealed nor-
mal neutrophil morphology but an inability to engulf labeled
BioParticles (Fig. 3C).
We next investigated whether neutrophils exposed to
flavored e-liquids exhibited altered proinflammatory cyto-
kine production. All flavored e-liquids, with the exception
of Solid Menthol and Sini-cide, induced a significant in-
crease in neutrophil IL-8 secretion (Fig. 3D). Specifically,
Kola (1 and 0.5%), Hot Cinnamon Candies (0.5%), Banana
Pudding (1, 0.5, and 0.25%), Menthol Tobacco (1%), and
Banana (1%) significantly increased IL-8 production rela-
tive to the PG/VG vehicle control. The Sini-cide e-liquid did
not stimulate IL-8 secretion; however, this is likely because
Fig. 2. Effects of flavored e-liquids on alve-
olar macrophage cytokine secretion. Alveo-
lar macrophages were challenged with 1,
0.5, and 0.25% e-liquid dilutions for 24 h
and evaluated for changes in interleukin
(IL)-6 (A) and IL-8 (B) protein secretion
(n  5). Data are presented as means 
 SE.
Significance: *P 	 0.05 and ***P 	 0.001
compared with vehicle control.
of the significant cytotoxicity observed with the 1 and 0.5%
challenges.
In addition to phagocytosis, neutrophils exert their anti-
bacterial function via the formation of NETs. To assess the
impact of e-liquids on NET generation, primary human neu-
trophils were incubated with 1% e-liquids diluted in cell
culture medium alone or in the presence of 25 nM PMA, a
PKC agonist and potent activator of NET formation. Challenge
of neutrophils with a 1% dilution of PG/VG with and without
25 nM PMA did not induce or alter NET formation compared
with NET formation generated with media alone and media
with 25 nM PMA (Fig. 4A). Similar to PG/VG, e-liquid
challenges without the addition of PMA did not stimulate
normal NET formation; however, 1% Sini-cide induced chro-
matin release at all time points (Fig. 4B). The pattern of
chromatin extrusion observed with the Sini-cide challenge did
not follow the oxidant-driven temporal progression of NET
formation (13, 19) or the rapid oxidant-independent generation
of NETs (54), suggesting e-liquid-induced cytotoxicity and cell
lysis. To assess whether flavored e-liquids alter normal NET
formation, neutrophils were challenged with 1% e-liquid dilu-
tions containing 25 nM PMA, and NET extrusion was quanti-
fied over 4 h. Stimulation of neutrophils with 1% Kola signif-
icantly enhanced chromatin release at 3 h, whereas challenge
with 1% Hot Cinnamon Candies suppressed PMA-induced
NET formation at 4 h (Fig. 4C). Exposure to 1% Sini-cide
resulted in a similar pattern of chromatin release observed in
the challenge without PMA. To visualize the time-dependent
effects of these e-liquids on NET formation, we fixed neutro-
phils at the various time points and examined cellular mor-
phology and markers of NET formation, such as disintegration
of nuclear membranes, nuclear material filling the cytoplasm
and mixing with cellular granules, and complete loss of nuclear
and granular integrity (12) using confocal microscopy. Figure
Fig. 3. Effects of flavored e-liquids on neutrophil phagocytosis. Neutrophils were challenged with 1, 0.5, and 0.25% dilutions of PG/VG vehicle (A) or e-liquids
(B) for 30 min before addition of S. aureus BioParticles. Phagocytosis was assessed 4 h after the addition of Bioparticles (n  5). C: fluorescent confocal
microscopy of neutrophils challenged with 0.25% “Kola,” “Hot Cinnamon Candies,” and Sini-cide. D: neutrophils were challenged with 1, 0.5, and 0.25%
e-liquid dilutions for 4 h and evaluated for changes in IL-8 secretion (n  3). Data are presented as means 
 SE. Significance: *P 	 0.05, **P 	 0.01, and
***P 	 0.001 compared with vehicle control.
4D indicates that Sini-cide was cytotoxic, resulting in chroma-
tin release by cell lysis within the 1st h of exposure, confirming
the nonspecific release of DNA seen in Fig. 4, B and C.
Interestingly, stimulation with Kola in the presence of PMA
appeared to expedite the steps associated with NET formation,
with complete loss of nuclear and granular integrity seen at 3 h,
rather than 4 h. In addition, stimulation with Hot Cinnamon
Candies appeared to block progression of NET formation.
These data suggest that stimulation with Kola and Hot Cinna-
mon Candies has differential effects on NET formation. Fur-
thermore, the visual illustration in Fig. 4D largely reflects the
quantitative assessment of chromatin release reported in Fig. 4,
B and C.
Numerous studies have reported that nicotine elicits a vari-
ety of immune suppressive responses (31, 58, 59) and prolongs
neutrophil survival (3, 43, 70). To investigate whether nicotine
could alter the observed e-liquid-induced suppression of neu-
trophil phagocytosis, we added nicotine to the PG/VG vehicle,
Kola, Hot Cinnamon Candies, and Sini-cide e-liquids at con-
centrations commonly found in commercially available e-liq-
uids (0.6, 1.2, 1.8, and 2.4 mg/ml). Stimulation with a 0.25%
dilution of e-liquids with and without nicotine did not signif-
icantly affect neutrophil phagocytosis beyond the effects ob-
served with the different flavored e-liquids alone (Fig. 5A). In
addition, emerging evidence indicates that thermal decompo-
sition of e-liquids during the vaping process can modify the
chemical composition of the aerosol mixtures (35). To examine
whether and how aerosolization of e-liquids affects the sup-
pressive effects on neutrophil phagocytosis, we prepared VEC,
similar to previously published methods (52). Figure 5B shows
that stimulation of neutrophils with PG/VG vehicle, Kola, Hot
Cinnamon Candies, or Sini-cide VEC did not significantly alter
neutrophil phagocytosis compared with the unheated e-liquid
challenges. These data suggest that vaping and aerosolization
of these e-liquids do not significantly modify the ability to
suppress neutrophil phagocytosis.
Effects of flavored e-liquids on NK cells. To evaluate the
impact of flavored e-liquids on normal NK cell function, we
exposed NK cells to flavored e-liquids in cell culture medium
before incubation with fluorescently labeled K562 leukemia
target cells. Based on the previous results in macrophages and
neutrophils, we focused our analysis on the 0.25% e-liquid
Fig. 4. Effects of flavored e-liquids on neutrophil extracellular trap (NET) formation. Quantitation of nucleic acid released during challenge with a 1% dilution
of PG/VG vehicle (A) or e-liquid challenges with 25 nM phorbol 12-myristate,13-acetate (PMA, B) and without 25 nM PMA (C) (n  3). D: confocal
immunofluorescence microscopy of neutrophils challenged with 1% flavored e-liquids, with and without 25 nM PMA. Data are presented as means 
 SE.
Significance: *P 	 0.05 and *** P 	 0.001 compared with vehicle control.
dilution. Following 4 h incubation, the ability of the NK cells
to eliminate target cells was determined using flow cytometry
(Fig. 6A). Killing of target cells was suppressed by cinnamon-
flavored e-liquids. Specifically, 0.25% Hot Cinnamon Candies
and 0.25% Sini-cide reduced the killing efficiency of NK cells
compared with the PG/VG vehicle control (Fig. 6, A and B).
Reductions in NK cell killing capacity were not the result of a
loss of NK cell viability (data not shown).
Chemical composition of flavored e-liquids. GC-coupled MS
was used to determine the qualitative chemical composition of
the seven flavored e-liquids used for this study. Spiro[1,3-
dioxolane-2,2=(1=H)-naphthalene]-, 3=,4=-dihydro-, vinyl trans-
cinnamate, and cinnamaldehyde were present in the Kola, Hot
Cinnamon Candies, and Sini-cide flavored e-liquids [Table S1
(Supplemental data for this article is available on the Journal
website.)]. Quantitative MS analysis for cinnamaldehyde con-
Fig. 5. Effects of nicotine and vaping on e-liquid-induced changes in neutrophil phagocytosis. Nicotine was added to the Kola, Hot Cinnamon Candies, Sini-cide,
and PG/VG vehicle e-liquids at concentrations commonly stocked in vape shops (2.4, 1.8, 1.2, and 0.6%). A: nicotine-containing e-liquids were diluted to 0.25%
in cell culture medium, and neutrophils were challenged for 30 min before the addition of S. aureus BioParticles. Phagocytosis was assessed 4 h after the addition
of Bioparticles (n  4). B: Kola, Hot Cinnamon Candies, Sini-cide, and “PG/VG” e-liquids were “vaped” to generate vaped e-liquid condensates (VECs).
Neutrophils were challenged with 0.25% dilutions of Kola, Hot Cinnamon Candies, Sini-cide, and PG/VG e-liquids or VECs for 30 min before the addition of
S. aureus BioParticles. Phagocytosis was assessed 4 h after the addition of Bioparticles (n  3). Data are presented as means 
 SE. Significance: **P 	 0.01
and ***P 	 0.001 compared with vehicle control.
tent in these flavored e-liquids revealed that the Kola, Hot
Cinnamon Candies, and Sini-cide contained 0.896 
 0.360,
39.328 
 3.414, and 1,131.0 
 19.9 mM, respectively (Table
1). Based on these measured concentration of cinnamaldehyde
in the neat e-liquids, we extrapolated the concentrations of
cinnamaldehyde in the 1, 0.5, and 0.25% dilutions of Kola, Hot
Cinnamon Candies, and Sini-cide used to challenge cells. In
addition, we determined whether aerosolization of these e-liq-
uids modified the cinnamaldehyde content. As shown in Table
1, cinnamaldehyde was present in the VEC derived from Kola,
Hot Cinnamon Candies, and Sini-cide, but at lower concentra-
tions, likely reflecting wall loss caused by the system generat-
ing the condensate.
Effects of cinnamaldehyde on alveolar macrophage, neutro-
phil, and NK cell function. MS analysis revealed that cinnam-
aldehyde was a major flavoring component in Sini-cide, Hot
Cinnamon Candies, and Kola, and each of these e-liquids
impaired normal immune cell function in our study. To deter-
mine the specific contribution of cinnamaldehyde to the ob-
served immunosuppressive effects, we challenged alveolar
macrophages, neutrophils, and NK cells with various doses of
cinnamaldehyde diluted in cell culture medium and assessed
changes in functional end points. Alveolar macrophages were
incubated with cinnamaldehyde for 1 h before the addition of
S. aureus BioParticles. Changes in phagocytosis were assessed
after 4 h. A significant reduction in phagocytosis was observed
with cinnamaldehyde concentrations 312.5 M, whereas
cinnamaldehyde-induced cell death was only apparent at the 10
mM concentration (Fig. 7A). Similarly, neutrophils were chal-
lenged for 30 min with a broad range of cinnamaldehyde
concentrations, and phagocytosis of BioParticles was assessed.
Neutrophil phagocytosis was significantly inhibited at cinna-
Fig. 6. Effects of flavored e-liquids on natural killer (NK) cell-mediated cytotoxicity. NK cells were incubated for 1 h with 0.25% e-liquids and then combined
with carboxyfluorescein succinimidyl ester (CFSE)-labeled K562 target cells for 4 h. A: flow cytometry analysis of CFSE bright target cells counter-labeled with
a far-red live/dead indicator. B: quantitation of NK cell-mediated killing of K562 leukemia target cells (n  5). Data are presented as means 
 SE. Significance:
*P 	 0.05 compared with vehicle control.
maldehyde concentrations of 10 M and greater. Viability was
significantly reduced with 5 and 10 mM cinnamaldehyde
exposures (Fig. 7B). To assess the direct effects of cinnamal-
dehyde on NK cell killing of target leukemia cells, NK cells
were challenged with a broad range of cinnamaldehyde con-
centrations for 1 h before incubation with fluorescently labeled
K562 target cells. Flow cytometry analysis revealed that NK
cell killing efficiency was significantly reduced with cinnam-
aldehyde challenges between 78 M and 1 mM. Exposure of
target cells to cinnamaldehyde concentrations 1.25 mM re-
sulted in significant cell death independent of NK cell activity.
Cinnamaldehyde significantly reduced NK cell viability at
concentrations of 625 M and greater (Fig. 7C). The inhibitory
(IC50) and cytotoxic (LC50) concentrations for cinnamaldehyde
on each end point in the respective cell type tested are reported
in Table 2.
Cinnamaldehyde is a potent electrophile that likely reacts
with free sulfhydryl groups on cysteine residues on proteins
(41). However, it is unclear whether the sulfhydryl-modifying
activity of cinnamaldehyde contributes to the observed sup-
pression of immune cell function. To investigate this potential
mechanism, we conducted competition experiments using the
small-molecule reducing agent DTT. Cinnamaldehyde-medi-
ated suppression of alveolar macrophage phagocytosis was
reversed by coexposure with cinnamaldehyde and DTT (Fig.
8), suggesting protein thiol modification as a potential mech-
anism for cinnamaldehyde-induced immune cell dysfunction.
DISCUSSION
Vaping e-cigarettes is frequently viewed as a safer alterna-
tive to cigarette smoking based on studies that have reported
substantially lower levels of known toxicants and carcinogens
commonly found in cigarette smoke (16, 24, 44, 66). Recent
publications have highlighted the potential risk for exposure to
reactive chemicals (1, 6, 9, 22, 60, 63) and toxicants (21, 35,
69), such as flavoring agents, not present in traditional cigarette
smoke. Furthermore, we recently demonstrated that vaping
e-cigarettes is associated with decreased expression of immune
genes in the nasal mucosa of human volunteers (42). However,
the manner by which these genomic alterations may affect
respiratory immune responses is not known. In the present
study, we evaluated the effects of seven flavored e-liquids on
respiratory innate immune cell function by exposing human
alveolar macrophages, neutrophils, and NK cells to varying
dilutions of e-liquid and VEC. In addition to identifying
flavor-specific and dose-dependent decreases in functional end
points across all three human primary immune cell types, our
data demonstrate that cinnamaldehyde-containing e-liquids
had the most immunosuppressive effects across the different
end points and cell types examined. Exposure of alveolar
macrophages, neutrophils, and NK cells to a broad range of
cinnamaldehyde spanning seven orders of magnitude estab-
lished a dose-response relationship for cinnamaldehyde-in-
duced suppression of human immune cell function, supporting
a direct cause-and-effect relationship between exposure to
cinnamaldehyde-containing e-liquids and suppression of respi-
ratory immune cell function. Furthermore, addition of the thiol
reducing agent DTT inhibited the effects of cinnamaldehyde on
alveolar macrophages, suggesting cinnamaldehyde-induced
thiolation as a potential mechanism mediating the observed
immune suppressive effects.
Cinnamon-flavored e-liquids are popular among e-cigarette
users and are often identified as “Best Sellers” by online
e-liquid retailers. However, some users have reported mouth,
throat, and respiratory irritation after vaping some cinnamon
e-liquids (8), and strong cinnamon-flavored e-liquids have
been reported to erode plastic tanks used on many second-
generation vaporizers (https://www.reddit.com/r/electronic_
cigarette/comments/1bnuo7/why_do_some_eliquids_crack_
plastic_tanks/). Several recent studies have illustrated the po-
tential for cinnamaldehyde to cause harm in the context of
e-cigarette and e-liquid exposures. Behar et al. evaluated the
effects of eight cinnamon-flavored refill fluids on human em-
bryonic stem cells and human adult pulmonary fibroblasts and
found that most of the e-liquids tested were cytotoxic (8).
Furthermore, they specifically attributed the observed e-liquid-
induced cytotoxicity to cinnamaldehyde and 2-methoxycinna-
maldehyde. More recently, Lerner et al. showed that human
lung fibroblasts exhibited cellular stress responses, morpholog-
ical changes, increased IL-8 secretion, and ultimately cell death
in response to challenge with a cinnamon-flavored e-liquid
(40). Our data reveal that both cinnamon-flavored e-liquids and
cinnamaldehyde suppress immune cell function in each cell
type tested in a dose-dependent manner at concentrations
below levels causing cytotoxicity (Table 2). Thus, our data
establish a direct link between a specific flavoring chemical
used in e-liquids and suppression of respiratory immune cell
function.
Innate immune cells of the respiratory system, which consist
predominately of alveolar and airway macrophages, neutro-
phils in the perialveolar vasculature, and NK cells in the nasal
passages and sinuses (30), play an essential role in eliminating
inhaled pathogens and damaged host cells to prevent infection
and injury. Toxicants that impair the innate immune functions
of these cell types, by either aberrant activation or suppression,
would therefore disrupt respiratory immune system homeosta-
sis and increase potential susceptibility to respiratory infec-
tions. Hwang et al. recently reported that e-cigarette vapor
extract reduced both macrophage and neutrophil antimicrobial
activity against S. aureus (31). However, the effect was attrib-
uted to nicotine, PG, and glycerin rather than specific flavoring
agents. We report here that acute exposure of human alveolar
macrophages and neutrophils to various flavored e-liquids
reduced phagocytosis of S. aureus; however, the impaired
clearance we observed was flavor specific, with phagocytosis
being suppressed more broadly in neutrophils (Figs. 1 and 3).
Moreover, the addition of nicotine to our e-liquid challenges
did not significantly alter the suppression of phagocytosis
Table 1. Quantitation of cinnamaldehyde in e-liquids
and vaped e-liquid condensates
Kola Hot Cinnamon Candies Sini-cide
Neat e-liquid, mM 0.896 
 0.360 39.32 
 3.41 1,131 
 19.9
Dilution, mM
1%† 0.00896 0.393 11.31*
0.5%† 0.00448 0.197 5.66*




 0.035 9.807 
 0.743 183.9 
 4.089
Values are means 
 SD. *Units are mM. †Cinnamaldehyde in e-liquid
dilutions is extrapolated from neat e-liquid measurements.
observed with exposure to nicotine-free e-liquids (Fig. 5).
Although nicotine, at sufficient concentrations, may indepen-
dently suppress innate immune cell activation and impair the
clearance of S. aureus, our data illustrate that chemical flavor-
ings likely contribute to the suppression of key respiratory
immune cell functions. Indeed, previous work by Kim et al.
found that cinnamaldehyde alters immune responses in mono-
cyte and macrophage cell lines by thiolation of target cysteine
residues, supporting the notion that a more direct mode of
action, such as protein modification, mediates the cinnamalde-
hyde-induced suppression of macrophage immune function
(36). To investigate whether the sulfhydryl-modifying activity
of cinnamaldehyde mediates suppression of respiratory innate
immune cell function, we conducted competition experiments
using the small-molecule reducing agent DTT. The observed
cinnamaldehyde-mediated suppression of alveolar macrophage
Fig. 7. Effects of cinnamaldehyde on alveo-
lar macrophage, neutrophil, and NK cell
function. Alveolar macrophages (A) (n  3)
and neutrophils (B) (n  3) were challenged
with a broad range of cinnamaldehyde concen-
trations. Cinnamaldehyde-induced changes in
BioParticle phagocytosis and cell viability
were evaluated by flow cytometry. C: NK cells
(n  3) were challenged with a broad range of
cinnamaldehyde concentrations, and changes
in cell-mediated killing of K562 leukemia cells
and NK cell viability were quantified using
flow cytometry. Data are presented as means 

SE. Extrapolated e-liquid concentrations of
cinnamaldehyde for each dilution tested (1, 0.5,
and 0.25%) are indicated within each panel.
phagocytosis was reversed by coexposure with DTT, suggest-
ing that the sulfhydryl-modifying activity of cinnamaldehyde
correlates with cinnamaldehyde-induced reductions in phago-
cytic capacity (Fig. 8). Although these data strongly suggest
that interactions between cinnamaldehyde and susceptible nu-
cleophilic residues of proteins are driving cinnamaldehyde-
mediated impairments of immune cell function, further work is
needed to determine which proteins are adducted and which
cellular pathways are affected.
Neutrophils play an essential role in protecting the airways
from bacterial infection by common inhaled pathogens, includ-
ing Streptococcus pneumoniae (20), Klebsiella pneumoniae
(33), Legionella pneumophila (65), and S. aureus (48). In
healthy individuals, phagocytosis of bacterial pathogens stim-
ulates the production of reactive oxygen species (ROS), which
in turn facilitates the release of microbicide granule compo-
nents into phagosomes. Tobacco smoke impairs respiratory
burst activation and thereby compromises the antibacterial
function of neutrophils (49). Furthermore, recent studies of
neutrophil function (including cell migration, ROS generation,
degranulation, phagocytosis, and NET generation) in COPD
patients indicate impaired responses that predispose toward
reduced bacterial clearance and increased inflammation (62).
Acrolein, an ,-unsaturated aldehyde found in cigarette
smoke, impairs neutrophil function by depleting glutathione
levels and suppressing NADPH oxidase activity by the direct
alkylation of cysteine residues in proteins involved in NADPH
oxidase activation (49). Although levels of acrolein in e-liquids
and e-cigarette aerosols are reported to be substantially lower
than those present in cigarette smoke (24), ,-unsaturated
aldehyde flavorings, such as cinnamaldehyde, may impair
neutrophil function by a similar mechanism. Our results indi-
cate that cinnamaldehyde-containing e-liquids suppress neutro-
phil phagocytosis of S. aureus in a dose-dependent manner
(Fig. 3, A and B), and subsequent challenge with cinnamalde-
hyde alone recapitulated the effect (Fig. 7B). Moreover, cin-
namaldehyde-induced inhibition of phagocytosis was observed
at low micromolar concentrations (IC50  32.4 
 12.9 M),
more than two orders of magnitude lower than those eliciting
cytotoxicity (LC50  3.35 
 0.84 mM) (Table 2).
Neutrophils also eliminate bacterial pathogens by expelling
extracellular traps composed of chromatin and antimicrobial
peptides originating from intracellular vesicles (11, 19, 62).
NET formation is initiated by stimulation of surface receptors,
including Toll-like receptors, cytokine receptors, and fragment
crystallizable receptors, resulting in activation of PKC and the
NADPH oxidase complex (26, 62). Whereas the exact role
of NETs in respiratory disease remains unclear, accumulation
of NETs has been implicated in the pathogenesis of numerous
noninfectious diseases, inflammatory disorders, and autoim-
mune disorders, including cystic fibrosis, asthma, and COPD
(27). Less is known about the consequences of impaired NET
formation; however, the developmental syndrome of neonatal
neutrophil dysfunction is characterized by compromised NET
generation and increases susceptibility for neonatal septicemia
and other infectious complications in human neonates (71).
Our finding that 1% Kola (8.96 M cinnamaldehyde) signifi-
cantly increased the rate of PMA-induced NET formation,
whereas 1% Hot Cinnamon Candies (393.28 M cinnamalde-
hyde) significantly decreased the rate of PMA-induced NET
formation, suggests that cinnamaldehyde may elicit a concen-
tration-dependent bimodal response (Fig. 4). Aberrant NET
activation, such as we observed during the 1% Kola e-liquid
exposure, may increase NET-mediated tissue damage and
respiratory dysfunction. Alternatively, inhibition of NET for-
mation, such as we observed with exposure to the 1% dilution
of Hot Cinnamon Candies e-liquid, may allow for enhanced
dissemination of bacterial pathogens in the lungs and increase
the risk of respiratory infections.
NK cells are a subset of cytotoxic lymphocytes that serve as
sentinels of the immune system by recognizing and killing
virus-infected and tumor cells. Unlike other lymphocytes, NK
cells do not require previous sensitization to recognize com-
promised cells; rather, they use activating and inhibiting re-
ceptors to interrogate host cells for molecular changes indica-
tive of damage or infection (68). NK cells lyse host cells
presenting abnormal surface antigens via exocytosis of cyto-
toxic perforin and granzymes. Studies indicate that smoking is
associated with reduced numbers of circulating NK cells (67),
and cigarette smoke reduces NK cell-mediated killing of can-
cer cells in vitro (17). Furthermore, our group reported that NK
cells are a major immune cell type in human nasal passages,
and influenza-induced cytotoxic NK cell responses are sup-
pressed in smokers (30). Here, we expanded on the current
literature by evaluating the effects of flavored e-liquids and
cinnamaldehyde flavoring on NK cell function. Our data indic-
Fig. 8. Coexposure of alveolar macrophages with cinnamaldehyde and DTT
reverses cinnamaldehyde-induced suppression of phagocytosis. Alveolar mac-
rophages were challenged with cell culture medium, 500 M DTT, 500 M
cinnamaldehyde, or 500 M DTT and 500 M cinnamaldehyde, and changes
in BioParticle phagocytosis were evaluated (n  3). Data are presented as
means 
 SE.
Table 2. The inhibitory and cytotoxic potential of
cinnamaldehyde on human primary alveolar macrophages,
neutrophils, and NK cells
Alveolar Macrophages Neutrophils NK Cells
IC50, mM 0.243 
 0.0593 0.0324 
 0.0129 0.0205 
 0.0054
LC50, mM 6.984 
 0.942 3.352 
 0.838 3.133 
 0.732
Values are means 
 SD. NK, natural killer; IC50, half-maximal inhibitory
concentration; LC50, half-maximal cytotoxic concentration.
ate that exposure of NK cells to 0.25% dilutions of two
cinnamon-flavored e-liquids in our panel suppressed NK cell
cytotoxic function, as measured by the ability to kill leukemia
target cells (Fig. 5). Exposure to cinnamaldehyde alone reca-
pitulated this effect, inhibiting NK cell killing at low micro-
molar concentrations (IC50  20.5 
 5.4 M) (Fig. 7 and
Table 2). To our knowledge, we are the first to report that
flavored e-liquids and cinnamaldehyde, a common flavoring
agent, can suppress NK cell-mediated killing of target cells,
which could have implications for their ability to kill both
tumorigenic and virus-infected host cells.
Flavoring agents, which were banned from use in traditional
cigarettes by the FDA in 2009, are broadly used in the manu-
facture of e-cigarettes and refill e-liquids (73) and contribute to
the surging popularity of these products (15). A precedent for
food-safe chemical flavorings causing inhalational injury was
established in May 2000 when eight workers at a microwave
popcorn-processing facility developed bronchiolitis obliterans,
an irreversible obstructive disease of the bronchioles, as a
result of exposure to the aerosolized butter flavoring diacetyl
(39). A recent study published by Allen et al. screened 51
unique flavored e-liquids for the presence of diacetyl, acetoin,
and 2,3-pentanedione (1) and revealed that 47 of 51 e-liquids
contained at least one of the potentially hazardous butter-
flavoring chemicals. In addition to the butter flavorings, recent
in vitro studies report that the cytotoxic effects of e-liquids
were largely the result of chemical flavorings (7, 25). Bahl el
al. evaluated the cytotoxicity of 41 e-liquids on human pulmo-
nary fibroblasts, human embryonic stem cells, and mouse
neural stem cells. They report that cytotoxicity varied by
product; however, cytotoxicity did not result from nicotine
exposure but rather correlated with the number and concentra-
tion of chemicals used to flavor fluids (5). More recently,
Gerloff et al. evaluated lung epithelial cell and fibroblast
inflammatory responses following exposure to various e-ciga-
rette flavoring chemicals. Their data indicate that ortho-vanil-
lin, acetoin, and maltol stimulate proinflammatory cytokine
(IL-8) secretion in lung epithelial cells and fibroblasts. Further-
more, the authors report that exposure of airway epithelial cells
to diacetyl, coumarin, acetoin, maltol, and cinnamaldehyde
resulted in a significant and persistent loss of epithelial barrier
function (22). Taken together, previous reports and our data
shown here demonstrate a clear dose-response relationship
between levels of cinnamaldehyde occurring in commercially
available e-liquids and suppressed function of human respira-
tory immune cells. These findings add to the concern that
flavored e-liquids may broadly contain potentially hazardous
chemicals and illustrate the need to investigate the respiratory
effects of common flavorings used in the manufacture of
e-liquids.
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